eli lilly oral glp 1 stock soars on encouraging results for daily weight-loss pill Medscape | Orforglipron, Eli Lilly's
Description
The highest dose 1.2mg does match the weight loss curve of 5mg of tirzepatide, with around 14% loss but certainly not the higher doses of tirzepatide which were around 17-18% at 36 weeks
Compounded medications are not mass-produced and are not reviewed or approved by the FDA for safety or efficacy
D-RL, J-YJ, and H-CZ revised the manuscript
10 Virtually, all RCTs evaluating GLP-1RA were designed to evaluate weight change as a primary outcome
Nexa offers compounded Tirzepatide (GLP-1/GIP) prepared by licensed pharmacies for qualifying patients
